Know Cancer

or
forgot password

    • cancer clinical trials in mesa, AZ

    • Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Banner Baywood Medical Center

    Trial Locations
    Banner Baywood Medical Center
    Banner Desert Medical Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Banner Baywood Medical Center

    Trial Locations
    Banner Baywood Medical Center
    Banner Desert Medical Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.
    Research Site
    Mesa, Arizona
    Bone Metastases in Subjects With Advanced Breast Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Mesa, Arizona
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
    Research Site
    Mesa, Arizona
    Cancer, Carcinoma, Fallopian Tube Cancer, Gynecological Malignancies, Metastases, Oncology, Ovarian Cancer, Solid Tumors, Tumors
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Mesa, Arizona
    Recurrent Glioblastoma
    Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
    Research Site
    Mesa, Arizona
    Breast Cancer, Breast Neoplasms, Breast Tumors, Cancer, Locally Recurrent and Metastatic Breast Cancer, Metastases, Metastatic Cancer, Oncology, Solid Tumors, Tumors
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Mesa, Arizona
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
    Research Site
    Mesa, Arizona
    Cancer, Hematologic Malignancies, Multiple Myeloma, Oncology, Bone Metastases, Multiple Myeloma Bone Lesions
    Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
    Research Site
    Mesa, Arizona
    Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
    TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
    Research Site
    Mesa, Arizona
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
    AMG 172 First in Human Study in Patients With Kidney Cancer
    Research Site
    Mesa, Arizona
    Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma
    Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
    Research Site
    Mesa, Arizona
    N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
    Iressa Expanded Access Program (EAP)
    Research Site
    Mesa, Arizona
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Banner Baywood Medical Center

    Trial Locations
    Banner Baywood Medical Center
    Banner Desert Medical Center
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Banner Desert Medical Center
    Mesa, Arizona 85202
    Brain and Central Nervous System Tumors
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Mesa, Arizona
    Colorectal Cancer, Metastases
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Mesa, Arizona
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
    Research Site
    Mesa, Arizona
    Squamous Cell Carcinoma of the Head and Neck
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Mesa, Arizona
    Diabetes Mellitus, Type 2
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Mesa, Arizona
    Type 2 Diabetes Mellitus
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Mesa, Arizona
    Refractory Melanoma
    Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
    Research Site
    Mesa, Arizona
    Tumors, Lymphoma
    Dose/ Schedule Finding Trial of AMG 531 for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
    Research Site
    Mesa, Arizona
    Lung Cancer, Chemotherapy-Induced Thrombocytopenia, Non-small Cell Lung Cancer, Cancer, Lung Neoplasms, Oncology, Solid Tumors, Thrombocytopenia
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Banner Desert Medical Center
    Mesa, Arizona 85202
    Leukemia
    Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Mesa, Arizona
    Non-Hodgkin's Lymphoma
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Mesa, Arizona
    Non-metastatic Prostate Cancer
    A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
    Research Site
    Mesa, Arizona
    Glioblastoma Multiforme